Skip to main content
Figure 2 | BMC Pediatrics

Figure 2

From: Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment

Figure 2

Immunologic and anthropometric outcomes over time. Mean CD4 percent (A) and CD4 count (B), weight-for-age z-score (WAZ) (C) and height-for-age z-score (HAZ) (D) before treatment, at randomization, and at scheduled visits with measurements through 148 weeks after randomization in Neverest 2 by sex and randomization group; Abbreviations: WAZ, weight-for-age z-score; HAZ, height-for-age z-score; LPV/r, lopinavir-boosted ritonavir; NVP, nevirapine.

Back to article page